Weize Yang
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 3
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Xiaomin Luo (5 shared papers)Hongxia Xia (5 shared papers)Xiaojie Yan (2 shared papers)Yu Liu (1 shared paper)Jun Xiong (1 shared paper)Benchao Wang (2 shared papers)Tangxi Guo (2 shared papers)Bicheng Zhang (1 shared paper)
- Journals
- Clinical Infectious Diseases (1 paper)Bioscience Reports (1 paper)Cell Biology International (1 paper)Disease Markers (1 paper)Molecular Medicine Reports (1 paper)
- Partner nations
- China
In The Last Decade
Weize Yang
8 papers receiving 337 citations
Peers
Comparison fields: 5 of 67
- Infectious Diseases 235
- Neurology 127
- Critical Care and Intensive Care Medicine 24
- Oncology 74
- Obstetrics and Gynecology 18
Countries citing papers authored by Weize Yang
This map shows the geographic impact of Weize Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Yang more than expected).
Fields of papers citing papers by Weize Yang
This network shows the impact of papers produced by Weize Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Yang. The network helps show where Weize Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weize Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 285 | |
| 2 | 2020 | 17 | |
| 3 | 2020 | 12 | |
| 4 | 2021 | 10 | |
| 5 | 2020 | 7 | |
| 6 | Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis. | 2017 | 7 |
| 7 | 2019 | 6 | |
| 8 | 2022 | 5 |
About Weize Yang
Weize Yang is a scholar working on Infectious Diseases, Neurology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 8 papers that have together received 349 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Long-Term Effects of COVID-19 (2 papers), Mesenchymal stem cell research (1 paper), Trauma and Emergency Care Studies (1 paper), MicroRNA in disease regulation (1 paper), Inflammation biomarkers and pathways (1 paper), Emergency and Acute Care Studies (1 paper) and Endoplasmic Reticulum Stress and Disease (1 paper). The work is most often cited by research in Infectious Diseases (235 citations), Neurology (127 citations), Critical Care and Intensive Care Medicine (24 citations), Oncology (74 citations) and Obstetrics and Gynecology (18 citations). Weize Yang has collaborated with scholars based in China. Frequent co-authors include Xiaomin Luo, Hongxia Xia, Xiaojie Yan, Yu Liu, Jun Xiong, Benchao Wang, Tangxi Guo, Bicheng Zhang, Wei Zhou and Lu Ye. Their work appears in journals such as Clinical Infectious Diseases, Bioscience Reports, Cell Biology International, Disease Markers and Molecular Medicine Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.